As of Feb 23
| +0.14 / +2.53%|
The 2 analysts offering 12-month price forecasts for Arcturus Therapeutics Ltd have a median target of 17.00, with a high estimate of 22.00 and a low estimate of 12.00. The median estimate represents a +199.30% increase from the last price of 5.68.
The current consensus among 2 polled investment analysts is to Buy stock in Arcturus Therapeutics Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.